Gisela Schwab, President Prod Development & Med Aff & CMO at EXELIXIS, INC. (EXEL), sold 22,500 shares at $20.56 ($463K) on 2018-08-01, disclosed to the SEC on 2018-08-03.
Seasonal sale ($463k) by President Prod Development & Med Aff & CMO — this insider has traded EXEL in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| EXEL | SELL | 2021-04-02 | $1.1M | — | Filing → |
| EXEL | SELL | 2021-02-19 | $2.2M | — | Filing → |
| EXEL | SELL | 2020-06-05 | $2.3M | — | Filing → |